In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 5, 1998, Pages 657-660

  Coudron, Philip E ^a   Stratton, Charles W ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH; CLARITHROMYCIN; METRONIDAZOLE; NITROFURANTOIN; TETRACYCLINE;

ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; DRUG COMBINATION; GRAM NEGATIVE INFECTION; GROWTH CURVE; HELICOBACTER PYLORI; NONHUMAN;

ANTACIDS; ANTI-BACTERIAL AGENTS; BISMUTH; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; NITROFURANTOIN; TETRACYCLINE;

EID: 0031771107     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.5.657     Document Type: Article

References (11)

1. Dunn, B. E., Cohen, H. & Blaser, M. J. (1997). Helicobacter pylori. Clinical Microbiology Reviews 10, 720-41.
2. Karim, Q. N. & Logan, R. P. H. (1996). Emerging patterns of Helicobacter pylori (H. pylori) antimicrobial susceptibility in Europe. Gut 39, Suppl. 3, A51.
3. Reddy, R., Osato, M., Gutierrez, O., Kim, J. G. & Graham, D. Y. (1996). Metronidazole resistance is high in Korea and Columbia and appears to be rapidly increasing in the US. Gastroenterology 110, Suppl., A238.
4. Goddard, A. F. & Logan, R. P. H. (1996). Antimicrobial resistance and Helicobacter pylori. Journal of Antimicrobial Chemotherapy 37, 639-43.
5. Chan, R., Lam, J. S., Lam, K. & Costerton, J. W. (1984). Influence of culture conditions on expression of the mucoid mode of growth of Pseudomonas aeruginosa. Journal of Clinical Microbiology 19, 8-16.
6. Coudron, P. E. & Stratton, C. W. (1995). Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori. Antimicrobial Agents and Chemotherapy 39, 2641-4.
7. Coudron, P. E. & Stratton, C. W. (1998). The bactericidal activity of clarithromycin versus ampicillin alone and in combination with omeprazole and/or bismuth against clarithromycin-susceptible and clarithromycin-resistant strains of Helicobacter pylori. Diagnostic Microbiology and Infectious Disease, in press.
8. Morgan, D., Kraft, W., Bender, M., Pearson, A. & The Gastrointestinal Physiology Working Group of Cayetano Heredia and The Johns Hopkins Universities. (1988). Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. Gastroenterology 95, 1178-84.
9. Borsch, G., Mai, U. & Muller, K. M. (1988). Monotherapy or polychemotherapy in the treatment of Campylobacter pylori-related gastroduodenal disease. Scandinavian Journal of Gastroenterology 142, Suppl., 101-6.
10. Contreras, A. & Vasquez, D. (1977). Cooperative and antagonistic interactions of peptidyl-tRNA and antibiotics with bacterial ribosomes. European Journal of Biochemistry 74, 539-47.
11. McOsker, C. C. & Fitzpatrick, P. M. (1994). Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. Journal of Antimicrobial Chemotherapy 33, Suppl. A, 23-30.